Importantly, we have documented the PPI models between METTL16 and eIF3a/b and determined which functionally essential amino acids (regions) of METTL16 are necessary for the interplays, which provides structural information to develop specific inhibitor(s) to abolish the interaction for cancer treatment. The gene discussed is METTL16; the disease is cancer.